Skip to content

Cambrex to Acquire Snapdragon Chemistry,  a Leader in Continuous Flow API Development Services

By asianet

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has entered into a definitive agreement to acquire Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma … Continued

New study reveals the extent of antibiotic misuse for a common sore throat, fuelling the 3rd leading cause of death worldwide

By asianet

A new global study launched during World Antimicrobial Awareness Week (WAAW, 18-24 November) shows a high dependence on antibiotics for treating respiratory conditions like sore throat, which is helping to fuel antibiotic resistance – the third leading cause of death worldwide, associated with 4.95 million deaths a year. The Sore Throat & Antibiotic Resistance (STAR) … Continued

MED-EL Presents: ideas4ears and calls for child inventors to aim high for people living with hearing loss

By asianet

Global children’s contest launched on World Inventors Day to raise awareness of hearing loss and the benefits of treatment Photo – https://mma.prnewswire.com/media/1946442/Aim_high_for_science.jpg Logo – https://mma.prnewswire.com/media/1860202/MED_EL_Logo.jpg MED-EL, a leading provider and inventor of hearing implant systems, today launched its annual worldwide search for inventions of the future through a global children’s contest, ideas4ears [ https://www.ideas4ears.org/enter/?utm_source=media&utm_medium=referral&utm_campaign=ideas4ears-launch2021 ]. … Continued

In operation the most innovative 11.74T MRI Core Magnet to be used on humans

By asianet

The world’s first simultaneous multi-channel/multi-nuclear 11.74T MRI system is currently under development at Gachon University Gil Medical Center (GUGMC). In the first Half of 2022 GUGMC successfully completed the Site Acceptance Test of the Magnet, which is a core part of the brain-specific ultra-precision 11.74T MRI that is being jointly developed with ASG Superconductors (ASG) … Continued

An end to smoking is within reach – it must not be allowed to slip away

By asianet

In a landmark new Global State of Tobacco Harm Reduction (GSTHR) report, experts are calling on global policymakers to seize the opportunity to bring about an end to smoking, which every year kills eight million people worldwide. Despite years of investment and effort, international tobacco control measures have stalled: the number of smokers has remained … Continued

Alphyn Biologics Completes First Cohort of Phase2a Clinical Trial of Topical Therapeutic for Mild-to-Moderate Atopic Dermatitis

By asianet

Alphyn Biologics ( https://c212.net/c/link/?t=0&l=en&o=3709054-1&h=2795132862&u=https%3A%2F%2Falphynbiologics.com%2F&a=Alphyn+Biologics ), a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced today that it has completed the first cohort of its Phase2a clinical trial of AB-101a, a topical therapeutic candidate for mild-to-moderate atopic dermatitis (AD) in adults and children as young as 2 years old. The first cohort enrolled AD patients without … Continued

RedHill Accelerates Opaganib’s Nuclear Radiation Protection Program – Positive Data Published

By asianet

Strong preclinical data, recently published in the International Journal of Molecular Sciences, from eight U.S government-funded in-vivo opaganib studies, supports opaganib’s potential as a nuclear radiation injury therapeutic for homeland security material threat medical countermeasures (MCM) and for antitumor radiotherapy As an oral, small molecule pill that is highly stable with a more than five-year … Continued

SENTINEL DIAGNOSTICS LAUNCHES SENTINAT(R) 200, THE FULLY AUTOMATED SAMPLE TO RESULT SYSTEM FOR THE DIAGNOSIS OF VIRAL INFECTIONS

By asianet

Sentinel CH. SpA today announced the launch of SENTiNAT(R) 200, the fully automated sample to result system, and SENT-NAT(R) SN200 Real-Time PCR assays for the quantitative detection of 10 viruses. SENTiNAT(R) 200 and STAT-NAT(R) SN200 kits represent the ideal solution for mid to large throughput laboratories engaged in the diagnosis of viral infections. SENTiNAT(R) 200 … Continued

TauRx Announces Additional Investment of USD119 million following announcement of Phase 3 LUCIDITY Topline Results

By asianet

– Substantial investment of USD119 million achieved by TauRx through a warrants exercise triggered by the announcement of LUCIDITY results in October, supporting HMTM regulatory submissions in UK, US and Canada, and preparation for market availability – Shareholder commitment to TauRx represents a significant success story for UK-based life sciences research and development in areas … Continued